<unk> , sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).<unk>  was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.
Pralatrexate
Trimetrexate
Abemaciclib
Afamelanotide
Cemiplimab
Mannomustine
Trifluridine
Lenalidomide